Literature DB >> 20576025

Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability.

P Sandgren1, M Hild, A Sjödin, H Gulliksson.   

Abstract

BACKGROUND: The novel TACSI system is designed for automated preparation of platelets (PLTs) from pooled buffy coats (BCs). One TACSI device will handle 6 units at the same time. The aim of our in vitro study is to investigate the effects of using this automated equipment with subsequent storage in two different plastic containers and to compare these results with PLTs prepared by the OrbiSac system. STUDY DESIGN AND METHODS: Buffy-coat-derived PLTs (n=8) were prepared by using the TACSI system, including storage in polyvinyl chloride (PVC)-based plastic containers with di, n-decyl phthalate (DnDP) (TACSI R) and BTHC (TACSI T)-based plasticizers. As a reference, the OrbiSac System was used to prepare PLTs (n=8) with subsequent storage in a PVC plastic container with a citrate-based plasticizer (BTHC). In total, 16 TACSI and eight reference units, supplied by approximately 30% plasma and 70% SSP+, were analysed for various in vitro variables during the 7-day storage period.
RESULTS: No significant difference in PLT counts, LDH, mean platelet volume (MPV) and adenosine triphosphate between the groups was detected. Glucose was lower (P<0·05) and lactate was higher (P<0·05) in TACSI R vs. OrbiSac. With exception of day 7 (P<0·05 TACSI R vs. OrbiSac), HSR reactivity were not different between groups. Extent of shape change was lower and CD62P higher in TACSI T when compared with TACSI R and OrbiSac units (P<0·05). pH was maintained at >6·8 (day 7) and swirling remained at the highest level (score=2) for all units throughout storage.
CONCLUSION: Platelets prepared by the TACSI system with subsequent storage in two different PVC-based plastic containers were equivalent to reference PLTs with regard to in vitro characteristics during 7 days of storage.
© 2010 The Author(s). Vox Sanguinis © 2010 International Society of Blood Transfusion.

Entities:  

Mesh:

Year:  2010        PMID: 20576025     DOI: 10.1111/j.1423-0410.2010.01364.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.

Authors:  Eva María Plaza; María Luisa Lozano; Isabel Sánchez Guiu; José Manuel Egea; Vicente Vicente; Laura Collantes De Terán; José Rivera
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

2.  Flow cytometry analysis of platelet populations: usefulness for monitoringthe storage lesion in pooled buffy-coat platelet concentrates.

Authors:  Dušan Vučetić; Vesna Ilić; Danilo Vojvodić; Vesna Subota; Milena Todorović; Bela Balint
Journal:  Blood Transfus       Date:  2016-12-21       Impact factor: 3.443

3.  Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently?

Authors:  Kim Anh Nguyen; Patricia Chavarin; Charles-Antoine Arthaud; Fabrice Cognasse; Olivier Garraud
Journal:  Blood Transfus       Date:  2012-07-12       Impact factor: 3.443

4.  A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.

Authors:  Kim Anh Nguyen; Hind Hamzeh-Cognasse; Marc Sebban; Elisa Fromont; Patricia Chavarin; Lena Absi; Bruno Pozzetto; Fabrice Cognasse; Olivier Garraud
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

5.  Residual red cells in blood components: A multisite study of fully automated enumeration using a hematology analyzer.

Authors:  Chloe Cavagnetto; Richard Alejo Blanco; Hollie McKenna; Laura Willmott; Elif Aydogdu; Nicola Akinyemi; Helena Standring; Simon Procter; Johan W Lagerberg; Elin Johansson; Harry Croxon; Dirk de Korte; Stephen F Garner; Atsushi Shirakami; Jarob Saker; Joachim Linssen; Rebecca Cardigan
Journal:  Transfusion       Date:  2020-11-17       Impact factor: 3.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.